KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Cash from Investing Activities (2016 - 2026)

Supernus Pharmaceuticals has reported Cash from Investing Activities over the past 15 years, most recently at -$51.3 million for Q4 2025.

  • Quarterly Cash from Investing Activities fell 306.0% to -$51.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.1 million through Dec 2025, up 102.16% year-over-year, with the annual reading at $4.1 million for FY2025, 102.16% up from the prior year.
  • Cash from Investing Activities was -$51.3 million for Q4 2025 at Supernus Pharmaceuticals, down from $48.7 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $239.8 million in Q1 2023 and troughed at -$82.2 million in Q3 2022.
  • The 5-year median for Cash from Investing Activities is -$39.6 million (2024), against an average of -$10.8 million.
  • Year-over-year, Cash from Investing Activities plummeted 1341.65% in 2022 and then surged 484.57% in 2023.
  • A 5-year view of Cash from Investing Activities shows it stood at $76.1 million in 2021, then tumbled by 164.05% to -$48.8 million in 2022, then crashed by 35.3% to -$66.0 million in 2023, then soared by 80.85% to -$12.6 million in 2024, then plummeted by 306.0% to -$51.3 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Cash from Investing Activities are -$51.3 million (Q4 2025), $48.7 million (Q3 2025), and -$30.6 million (Q2 2025).